The $10,000 bet that became $6.7M in 10 years (Cerebras breakdown)

Good afternoon!

Let's talk about money.

The story:

In May 2016, three venture firms, Benchmark, Eclipse, and Foundation Capital, wrote checks for a company trying to build something everyone said was impossible: a computer chip the size of a dinner plate.

That company was Cerebras. The valuation was $60 million (post-money).

Last Thursday, Cerebras IPO'd at $185/share. The stock popped 68% on day one. Market cap hit $60 billion.

The returns:

• Foundation Capital: Put in $37M. Got back $2.8B. 76x return.

• Eclipse: Put in $147M. Got back $2.5B. 17x return.

• Benchmark: Put in $268M. Got back $3.2B. 12x return.

What this newsletter is about:

We're going to break down every single funding round. Show you exactly what a $10,000 investment in each round would be worth today. And explain why this was one of the smartest and riskiest bets in private markets history.

Because here's the thing: Our Premium members saw this deal more than a year ago.

We profiled Cerebras in March 2025. Stock was trading on secondaries at $102-$107. We told you it was likely IPO'ing at the $150-160 range.

It IPO'd at $185. Then popped to $311.

If you'd bought at $105 (March 2025 secondary price), you're up 196% today.

But if you'd gotten in at Series A (2016), you'd be up 76,500%.

Let's break down every round.

Every valuation.

Every return. ☕

Jose, Alberto, and the Founderscrowd team.

🎁 We got you $100 in credits. Redeem now.

Last week Viktor wrote a brief, built a landing page, and opened a pull request.

Last week, wrote a campaign brief, built a landing page, opened a pull request, generated a board-ready PDF from live Stripe data, and sent a follow-up email to a churned customer. All from Slack. Same colleague that also pulls your reports and monitors your dashboards. 5,700+ teams. 3,000+ integrations.

💰 THE COMPLETE FUNDING BREAKDOWN

ROUND-BY-ROUND: FROM $60M TO $60B

📍 SERIES A: MAY 2016

What happened:

Benchmark, Eclipse, and Foundation Capital co-led the Series A. $6.5 million raised.

Valuation: $60 million post-money
Share price: ~$0.42 (estimated)
Lead investors: Benchmark, Eclipse, Foundation Capital

The pitch:

Build a chip using an entire silicon wafer. Not dozens of tiny chips diced from one wafer. One giant chip.

Every semiconductor expert said it was impossible. Heat. Power. Packaging. All unsolvable problems.

What $10,000 invested would be worth today:

• At IPO price ($185): $4,404,762

• At day-one close ($311): $7,404,762

• At current price (~$280): $6,666,667

Return: 44,048% at IPO, 74,048% at day-one peak, 66,567% today

Why this worked:

Foundation Capital partner Steve Vassallo saw something nobody else did: Andrew Feldman (CEO) had done this before. He co-founded SeaMicro and sold it to AMD for $334M.

Feldman had a track record. And he was crazy enough to try the impossible.

📍 SERIES B: DECEMBER 2016

What happened:

$26 million raised. 7 months after Series A.

Valuation: ~$150 million post-money (estimated)
Share price: ~$1.05 (estimated)
New investors: Coatue
Existing investors: Benchmark, Foundation, Eclipse

The pitch:

We designed the chip. Now we need to manufacture it.

Problem: No one has ever manufactured a wafer-scale chip before. TSMC (the world's best foundry) has never done this.

What $10,000 invested would be worth today:

• At IPO price ($185): $1,761,905

• At day-one close ($311): $2,961,905

• At current price (~$280): $2,666,667

Return: 17,619% at IPO, 29,519% at day-one peak, 26,567% today

Why this worked:

TSMC said yes. That was the de-risking moment.

If the world's best foundry believed it was possible, maybe it was possible.

📍 SERIES C: NOVEMBER 2017

What happened:

Amount not disclosed. Likely ~$40-50M.

Valuation: ~$300 million post-money (estimated)
Share price: ~$2.10 (estimated)
Investors: Existing investors

The pitch:

We manufactured the chip. Now we need to solve the packaging.

This is where Cerebras almost died.

What $10,000 invested would be worth today:

• At IPO price ($185): $880,952

• At day-one close ($311): $1,480,952

• At current price (~$280): $1,333,333

Return: 8,810% at IPO, 14,710% at day-one peak, 13,233% today

Why this was the scariest round:

Cerebras burned $8 million per month trying to solve packaging. They destroyed hundreds of chips. Board meetings were "walk of shame" sessions where Feldman reported another failure.

Series C investors were betting on a team that hadn't solved the core technical problem yet.

📍 SERIES D: NOVEMBER 2018

What happened:

Amount not disclosed. Likely ~$75M.

Valuation: ~$600 million post-money (estimated)
Share price: ~$4.20 (estimated)
New investors: Altimeter Capital
Existing investors: Benchmark, Foundation, Eclipse, Coatue

The pitch:

We're still trying to solve packaging. Give us more runway.

What $10,000 invested would be worth today:

• At IPO price ($185): $440,476

• At day-one close ($311): $740,476

• At current price (~$280): $666,667

Return: 4,405% at IPO, 7,305% at day-one peak, 6,567% today

The context:

This was 2018. Cerebras was burning cash. No revenue. No product. Just a really expensive science project.

Series D investors bet that Feldman's team would figure it out. Eventually.

📍 THE BREAKTHROUGH: JULY 2019

What happened:

Cerebras solved packaging.

They invented a machine that could bolt in 40 screws simultaneously to secure the wafer without cracking it. They solved cooling. They solved power delivery.

The founding team stood in the lab and watched the computer run.

"That was one of the greatest moments of my life," Feldman said.

This is the moment Series A-D investors had been waiting for.

📍 SERIES E: DATA NOT AVAILABLE

What happened:

Likely raised between 2019 and 2020. Amount and valuation not disclosed publicly.

The pitch:

We solved the impossible problem. Now we need to scale manufacturing and get customers.

📍 SERIES F: NOVEMBER 2021

What happened:

$250 million raised.

Valuation: $4 billion post-money
Share price: ~$28 (estimated)
New investors: Alpha Wave Global
Existing investors: Benchmark, Foundation, Eclipse, Coatue, Altimeter

The pitch:

We have customers. We have revenue. We're scaling.

What $10,000 invested would be worth today:

• At IPO price ($185): $66,071

• At day-one close ($311): $111,071

• At current price (~$280): $100,000

Return: 661% at IPO, 1,011% at day-one peak, 900% today

The context:

Series F was the first "safe" round. The company had product-market fit. Revenue was growing. Technical risk was gone.

But the return was also much lower. You're paying for de-risked growth, not moonshot potential.

📍 SERIES G: SEPTEMBER 2025

What happened:

$1.1 billion raised.

Valuation: $8.1 billion post-money
Share price: $56.50
Lead investors: Fidelity, Atreides Management
New investors: Tiger Global, Valor Equity, 1789 Capital
Existing investors: Benchmark, Foundation, Eclipse, Coatue, Altimeter, Alpha Wave

The pitch:

We're the fastest AI inference provider in the world. We're IPO'ing in 2026.

What $10,000 invested would be worth today:

• At IPO price ($185): $32,743

• At day-one close ($311): $55,044

• At current price (~$280): $49,557

Return: 227% at IPO, 450% at day-one peak, 396% today

The context:

Series G was a pre-IPO round. Institutional investors (Fidelity, Tiger) are piling in before the public listing.

Returns are lower, but liquidity is 4 months away. Much less risk.

📍 SERIES H: FEBRUARY 2026

What happened:

$1 billion raised.

Valuation: $23 billion post-money
Share price: ~$160 (estimated)
Lead investors: Tiger Global
New investors: AMD
Existing investors: Benchmark, Fidelity, Atreides, Alpha Wave, Altimeter, Coatue, 1789 Capital

The pitch:

We just signed a $10 billion deal with OpenAI. We're IPO'ing in 3 months.

What $10,000 invested would be worth today:

• At IPO price ($185): $11,563

• At day-one close ($311): $19,438

• At current price (~$280): $17,500

Return: 16% at IPO, 94% at day-one peak, 75% today

The context:

This was a bridge round. IPO was 3 months away. Investors wanted exposure before public listing.

Lowest risk. Lowest return. But guaranteed liquidity.

📊 THE RETURNS TABLE

IF YOU INVESTED $10,000 IN EACH ROUND...

🎯 THE LESSONS

1. EARLY = EVERYTHING

Series A investor: $10K → $6.7M (66,567% return)
Series H investor: $10K → $17.5K (75% return)

The difference between Series A and Series H is 10 years and 66,492 percentage points.

2. RISK = REWARD

Series A investors bet on:

• An impossible technical problem

• A CEO with one exit (SeaMicro for $334M)

• Zero revenue

• Zero product

Series H investors bet on:

• Proven technology

• $510M revenue

• $10B OpenAI contract

• IPO in 3 months

Series A risk: Could lose everything
Series A reward: 66,567%

Series H risk: Almost none
Series H reward: 75%

3. THE "DEATH ZONE" (2017-2019)

What happened:

Cerebras burned $200M trying to solve the packaging problem. $8M/month. Board meetings were disasters.

Series C and D investors (2017-2018) invested during the death zone.

They bet that Feldman would figure it out. They had no proof he would.

The payoff:

Series C: $10K → $1.3M (13,233%)
Series D: $10K → $667K (6,567%)

The lesson:

The best returns come from investing before the company solves the problem, not after.

4. SECONDARY MARKETS ARE REAL

March 2025: Cerebras shares trading at $102-$107 on Forge, EquityZen
May 2026 IPO: $185
Day one: $311

If you bought at $105 (secondary market), you're up 196% in 14 months.

Secondary markets let everyday investors access late-stage startups before IPO. No 10-year lockup. Liquidity in months, not years.

💎 WHAT FOUNDERSCROWD PREMIUM MEMBERS SAW

MARCH 2025: WE PROFILED CEREBRAS

What we told Premium members:

• Cerebras was trading on secondaries at $102-$107

• IPO expected in Q2 2026 at $150-160 range

• $510M revenue, $10B OpenAI contract

• Strong buy for investors who want AI infrastructure exposure

What happened:

• IPO'd at $185 (23% above high-end estimate)

• Popped to $311 on day one (68% gain)

• Currently trading at ~$280

If you'd bought at $105 in March 2025:

You're up 166% in 14 months. Annualized return: 142%.

If you'd bought at IPO ($185):

You're up 51% in 8 days.

🔥 WHY THIS MATTERS FOR YOU

1. THESE DEALS ARE ACCESSIBLE NOW

You don't need to be a VC to invest in companies like Cerebras.

Options:

• Secondary markets (Forge, EquityZen): Buy shares in late-stage private companies

• Publicly-traded VC funds (Robinhood RVI): Daily liquidity, no accreditation required

• Direct secondaries (platforms connecting buyers and sellers of private shares)

Cerebras was available on secondaries at $102-107 in March 2025. Anyone could have bought.

2. PREMIUM MEMBERS GET THESE DEALS EARLY

We profiled Cerebras in March 2025, 14 months before IPO.

We've profiled:

• SpaceX (IPO'ing June 2026 at $1.75-2T)

• Anthropic (likely IPO 2027)

• Anduril (likely IPO 2027 at $80-120B)

• Shield AI (raised $1.5B at $12.7B, March 2026)

All of these are accessible via secondaries or VC funds.

3. THE NEXT CEREBRAS IS OUT THERE

Cerebras went from $60M → $60B in 10 years.

1,000x return.

There are companies right now burning cash, solving impossible problems, pre-revenue, that will be the next $60B IPO.

The question:

Can you identify them? Can you get access? Can you stomach the risk?

Because the returns are life-changing. But the failures are total losses.

📊 THE BOTTOM LINE

Cerebras went from $60M to $60B in 10 years.

Series A investors: $10K → $6.7M (66,567%)
Series H investors: $10K → $17.5K (75%)
Secondary buyers (March 2025): $10K → $26.7K (166%)

The lesson:

Early investors win. But you don't have to be a VC anymore.

Secondary markets, publicly-traded VC funds (Robinhood RVI), and platforms like Forge/EquityZen let everyday investors access late-stage startups.

Cerebras was available at $102-107 in March 2025. Our Premium members saw it. Anyone could have bought it.

Now it's trading at $280.

The next Cerebras is out there.

The question is: Will you find it? Will you have access? Will you invest?

Because the returns are life-changing. But only if you're willing to bet on companies solving impossible problems before they succeed.

See you Saturday. Until then, keep hunting. ☕

Jose, Alberto, and the FC team.
Founderscrowd

P.S. Premium members: We're profiling 3 new late-stage companies in June. One is a defense-tech startup that raised $650M at a $4B valuation (True Anomaly). Another is a biotech company with FDA breakthrough designation (CREATE). And the third is an AI infrastructure play (Aria Networks, $125M Series A). All three are accessible via secondaries. All three could be the next Cerebras.

DISCLAIMER

Founderscrowd is an independent financial media company. We are not a registered investment adviser, broker-dealer, or FINRA/SEC-regulated entity. Nothing in this newsletter constitutes investment advice, a recommendation, or an offer to buy or sell securities.

Private market and pre-IPO investments carry substantial risk. You may lose some or all of your invested capital. These investments are illiquid and may not be suitable for all investors. Only invest what you can afford to lose entirely.

Deal opportunities are sourced from third-party platforms. Founderscrowd does not act as a broker-dealer or conduct independent due diligence. We may receive compensation for featuring certain opportunities, which creates a conflict of interest.

All Founderscrowd Premium memberships are non-refundable. The value is delivered upon access to information, which cannot be returned once shared.

Past performance is not indicative of future results. Conduct your own research and consult qualified advisers before investing.

© 2026 Founderscrowd. All rights reserved.